A comparison of the immunological potency of Burkholderia lipopolysaccharides in endotoxemic BALB/c mice

Microbiology and Immunology

Volumn 60, Issue 11, 2016, Pages 725-739

  Hsueh, Pei Tan ^a   Liu, Chiu Lin ^b   Wang, Hsuan Han ^b   Ni, Wei Fen ^b   Chen, Ya Lei ^b   Liu, Jong Kang ^a  

^a NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^b NATIONAL KAOHSIUNG NORMAL UNIVERSITY   (Taiwan)

Author keywords

Burkholderia bacteria; endotoxemia; lipopolysaccharide

Indexed keywords

3 HYDROXYHEXADECANOIC ACID; 3 HYDROXYTETRADECANOIC ACID; BACTERIAL ANTIGEN; BACTERIUM LIPOPOLYSACCHARIDE; BETA INTERFERON; CD11B ANTIGEN; CD14 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; CD62E ANTIGEN; CXCL9 CHEMOKINE; DECANOIC ACID; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; INTERLEUKIN 12P70; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; L SELECTIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; BACTERIUM ANTIBODY; BIOLOGICAL MARKER; CYTOKINE; ENDOTOXIN; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BONE MARROW CELL; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA PSEUDOMALLEI; BURKHOLDERIA THAILANDENSIS; CELL DIFFERENTIATION; CELL SUBPOPULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ELECTROPHORESIS; ENDOTOXEMIA; FEMALE; GAS CHROMATOGRAPHY; HUMAN; MASS SPECTROMETRY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BLOOD; BONE MARROW; BURKHOLDERIA; BURKHOLDERIA INFECTION; CYTOLOGY; DISEASE MODEL; IMMUNOLOGY; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; METABOLISM;

ANIMALS; ANTIBODIES, BACTERIAL; BIOMARKERS; BONE MARROW; BURKHOLDERIA; BURKHOLDERIA INFECTIONS; BURKHOLDERIA PSEUDOMALLEI; CYTOKINES; DISEASE MODELS, ANIMAL; ENDOTOXEMIA; ENDOTOXINS; FEMALE; IMMUNOPHENOTYPING; LIPOPOLYSACCHARIDES; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED BALB C; SPLEEN;

EID: 85002252545     PISSN: 03855600     EISSN: 13480421     Source Type: Journal    
DOI: 10.1111/1348-0421.12450     Document Type: Article

References (46)

1. Caroff M., Karibian D., Cavaillon J.M., Haeffner-Cavaillon N. (2002) Structural and functional analyses of bacterial lipopolysaccharides. Microbes Infect 4: 915–26.
2. Barkhausen T., Krettek C., van Griensven M. (2005) L-selectin: Adhesion, signalling and its importance in pathologic posttraumatic endotoxemia and non-septic inflammation. Exp Toxicol Pathol 57: 39–52.
3. Utaisincharoen P., Tangthawornchaikul N., Kespichayawattana W., Anuntagool N., Chaisuriya P., Sirisinha S. (2000) Kinetic studies of the production of nitric oxide (NO) and tumour necrosis factor-α (TNF-α) in macrophages stimulated with Burkholderia pseudomallei endotoxin. Clin Exp Immunol 122: 324–9.
4. Weehuizen T.A., Prior J.L., van der Vaart T.W., Ngugi S.A., Nepogodiev S.A., Field R.A., Kager L.M., van 't Veer C., de Vos A.F., Wiersinga W.J. (2015) Differential toll-like receptor-signalling of Burkholderia pseudomallei lipopolysaccharide in murine and human models. PLOS ONE 10: e0145397.
5. Zughaier S.M., Ryley H.C., Jackson S.K. (1999) Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor α from human monocytes. Infect Immun 67: 1505–7.
6. Novem V., Shui G., Wang D., Bendt A.K., Sim S.H., Liu Y., Thong T.W., Sivalingam S.P., Ooi E.E., Wenk M.R., Tan G. (2009) Structural and biological diversity of lipopolysaccharides from Burkholderia pseudomallei and Burkholderia thailandensis. Clin Vaccine Immunol 16: 1420–8.
7. Ierano T., Cescutti P., Leone M.R., Luciani A., Rizzo R., Raia V., Lanzetta R., Parrilli M., Maiuri L., Silipo A., Molinaro A. (2010) The lipid A of Burkholderia multivorans C1576 smooth-type lipopolysaccharide and its pro-inflammatory activity in a cystic fibrosis airways model. Innate Immun 16: 354–65.
8. Zhang S., Feng S.H., Li B., Kim H.Y., Rodriguez J., Tsai S., Lo S.C. (2011) In vitro and in vivo studies of monoclonal antibodies with prominent bactericidal activity against Burkholderia pseudomallei and Burkholderia mallei. Clin Vaccine Immunol 18: 825–34.
9. AuCoin D.P., Reed D.E., Marlenee N.L., Bowen R.A., Thorkildson P., Judy B.M., Torres A.G., Kozel T.R. (2012) Polysaccharide specific monoclonal antibodies provide passive protection against intranasal challenge with Burkholderia pseudomallei. PLoS ONE 7: e35386.
10. Ngugi S.A., Ventura V.V., Qazi O., Harding S.V., Kitto G.B., Estes D.M., Dell A., Titball R.W., Atkins T.P., Brown K.A., Hitchen P.G., Prior J.L. (2010) Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis. Vaccine 28: 7551–5.
11. Saldías M.S., Ortega X., Valvano M.A. (2009) Burkholderia cenocepacia O antigen lipopolysaccharide prevents phagocytosis by macrophages and adhesion to epithelial cells. J Med Microbiol 58: 1542–8.
12. Chen Y.S., Lin H.H., Hsueh P.T., Liu P.J., Ni W.F., Chung W.C., Lin C.P., Chen Y.L. (2015) Whole-genome sequence of an epidemic strain of Burkholderia pseudomallei vgh07 in Taiwan. Genome Announc 3: e00345–15.
13. Hsueh P.T., Liu J.K., Chen Y.L., Liu P.J., Ni W.F., Chen Y.S., Wu K.M., Lin H.H. (2015) Genomic sequence of Burkholderia multivorans NKI379, a Soil bacterium that inhibits the growth of Burkholderia pseudomallei. Genome Announc 3: e01294–15.
14. Chen Y.S., Lin H.H., Liu P.J., Tsai H.Y., Hsueh P.T., Liu H.Y., Chen Y.L. (2011) Use of 3-hydroxy fatty acid concentrations in a murine air pouch infection model as a surrogate marker for LPS activity: A feasibility study using environmental Burkholderia cenocepacia isolates. J Microbiol Methods 87: 368–74.
15. Wiersinga W.J., Currie B.J., Peacock S.J. (2012) Melioidosis. N Engl J Med 367: 1035–44.
16. Loutet S.A., Valvano M.A. (2010) A decade of Burkholderia cenocepacia virulence determinant research. Infect Immun 78: 4088–100.
17. Glass M.B., Gee J.E., Steigerwalt A.G., Cavuoti D., Barton T., Hardy R.D., Godoy D., Spratt B.G., Clark T.A., Wilkins P.P. (2006) Pneumonia and septicemia caused by Burkholderia thailandensis in the United States. J Clin Microbiol 44: 4601–4.
18. Lin H.H., Chen Y.S., Li Y.C., Tseng I.L., Hsieh T.H., Buu L.M., Chen Y.L. (2011) Burkholderia multivorans acts as an antagonist against the growth of Burkholderia pseudomallei in soil. Microbiol Immunol 55: 616–24.
19. Davis M.R., Jr, Goldberg J.B. (2012) Purification and visualization of lipopolysaccharide from Gram-negative bacteria by hot aqueous-phenol extraction. J Vis Exp 63: 3916.
20. Ieranò T., Silipo A., Sturiale L., Garozzo D., Brookes H., Khan C.M., Bryant C., Gould F.K., Corris P.A., Lanzetta R., Parrilli M., De Soyza A., Molinaro A. (2008) The structure and proinflammatory activity of the lipopolysaccharide from Burkholderia multivorans and the differences between clonal strains colonizing pre and posttransplanted lungs. Glycobiology 18: 871–81.
21. Lin H.H., Huang S.P., Hsieh H.C., Chen C.S., Chen Y.L. (2007) Performance characteristics of the limulus amebocyte lysate assay and gas chromatography-mass spectrum analysis of lipopolysaccharides relative to nitric oxide production by peritoneal exudates of cells. J Hazard Mater 145: 431–6.
22. Morgan E., Varro R., Sepulveda H., Ember J.A., Apgar J., Wilson J., Lowe L., Chen R., Shivraj L., Agadir A., Campos R., Ernst D., Gaur A. (2004) Cytometric bead array: a multiplexed assay platform with applications in various areas of biology. Clin Immunol 110: 252–66.
23. Brett P.J., Burtnick M.N., Snyder D.S., Shannon J.G., Azadi P., Gherardini F.C. (2007) Burkholderia mallei expresses a unique lipopolysaccharide mixture that is a potent activator of human Toll-like receptor 4 complexes. Mol Microbiol 63: 379–90.
24. Silipo A., Molinaro A., Ieranò T., De Soyza A., Sturiale L., Garozzo D., Aldridge C., Corris P.A., Khan C.M., Lanzetta R., Parrilli M. (2007) The complete structure and pro-inflammatory activity of the lipooligosaccharide of the highly epidemic and virulent gram-negative bacterium Burkholderia cenocepacia ET-12 (strain J2315). Chemistry 13: 3501–11.
25. Brown J., Wang H., Hajishengallis G.N., Martin M. (2011) TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J Dent Res 90: 417–27.
26. Meumann E.M., Cheng A.C., Ward L., Currie B.J. (2012) Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature. Clin Infect Dis 54: 362–9.
27. Laws T.R., Smither S.J., Lukaszewski R.A., Atkins H.S. (2011) Neutrophils are the predominant cell-type to associate with Burkholderia pseudomallei in a BALB/c mouse model of respiratory melioidosis. Microb Pathog 51: 471–5.
28. Woodman M.E., Worth R.G., Wooten R.M. (2012) Capsule influences the deposition of critical complement C3 levels required for the killing of Burkholderia pseudomallei via NADPH-oxidase induction by human neutrophils. PLOS ONE 7: e52276.
29. Chen L., Flies D.B. (2013) Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat Rev Immunol 13: 227–42.
30. Amemiya K., Dankmeyer J.L., Fetterer D.P., Worsham P.L., Welkos S.L., Cote C.K. (2015) Comparison of the early host immune response to two widely diverse virulent strains of Burkholderia pseudomallei that cause acute or chronic infections in BALB/c mice. Microb Pathog 86: 53–63.
31. Haque A., Easton A., Smith D., O'Garra A., Van Rooijen N., Lertmemongkolchai G., Titball R.W., Bancroft G.J. (2006) Role of T cells in innate and adaptive immunity against murine Burkholderia pseudomallei infection. J Infect Dis 193: 370–9.
32. Hume D.A. (2015) The many alternative faces of macrophage activation. Front Immunol 6: 370.
33. Woods C.W., Bressler A.M., LiPuma J.J., Alexander B.D., Clements D.A., Weber D.J., Moore C.M., Reller L.B., Kaye K.S. (2004) Virulence associated with outbreak-related strains of Burkholderia cepacia complex among a cohort of patients with bacteremia. Clin Infect Dis 38: 1243–50.
34. Hughes J.E., Stewart J., Barclay G.R., Govan J.R. (1997) Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia. Infect Immun 65: 4281–7.
35. De Soyza A., Ellis C.D., Khan C.M., Corris P.A., Demarco de Hormaeche R. (2004) Burkholderia cenocepacia lipopolysaccharide, lipid A, and proinflammatory activity. Am J Respir Crit Care Med 170: 70–7.
36. Ganesan S., Sajjan U.S. (2011) Host evasion by Burkholderia cenocepacia. Front Cell Infect Microbiol 1: 25.
37. Tirsoaga A., Novikov A., Adib-Conquy M., Werts C., Fitting C., Cavaillon J.M., Caroff M. (2007) Simple method for repurification of endotoxins for biological use. Appl Environ Microbiol 73: 1803–8.
38. de Pablo R., Monserrat J., Reyes E., Díaz D., Rodríguez-Zapata M., de la Hera A., Prieto A., Álvarez-Mon M. (2013) Circulating sICAM-1 and sE-Selectin as biomarker of infection and prognosis in patients with systemic inflammatory response syndrome. Eur J Intern Med 24: 132–8.
39. Kung C.T., Hsiao S.Y., Su C.M., Tsai T.C., Cheng H.H., Tsai N.W., Chang W.N., Huang C.R., Wang H.C., Lin W.C., Lin Y.J., Cheng B.C., Su Y.J., Lu C.H. (2013) Serum adhesion molecules as predictors of bacteremia in adult severe sepsis patients at the emergency department. Clin Chim Acta 421: 116–20.
40. Mizel S.B., Bates J.T. (2010) Flagellin as an adjuvant: Cellular mechanisms and potential. J Immunol 185: 5677–82.
41. Noah C.E., Malik M., Bublitz D.C., Camenares D., Sellati T.J., Benach J.L., Furie M.B. (2010) GroEL and lipopolysaccharide from Francisella tularensis live vaccine strain synergistically activate human macrophages. Infect Immun 78: 1797–806.
42. Kumar H., Kawai T., Akira S. (2011) Pathogen recognition by the innate immune system. Int Rev Immunol 30: 16–34.
43. Maeshima N., Fernandez R.C. (2013) Recognition of lipid A variants by the TLR4-MD-2 receptor complex. Front Cell Infect Microbiol 3: 3.
44. Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Huber M., Kalis C., Keck S., Galanos C., Freudenberg M., Beutler B. (2005) CD14 is required for MyD88-independent LPS signaling. Nat Immunol 6: 565–70.
45. Tuanyok A., Stone J.K., Mayo M., Kaestli M., Gruendike J., Georgia S., Warrington S., Mullins T., Allender C.J., Wagner D.M., Chantratita N., Peacock S.J., Currie B.J., Keim P. (2012) The genetic and molecular basis of O-antigenic diversity in Burkholderia pseudomallei lipopolysaccharide PLoS Negl Trop Dis. 6: e1453.
46. Cătană C.S., Berindan Neagoe I., Cozma V., Magdaş C., Tăbăran F., Dumitraşcu D.L. (2015) Contribution of the IL-17/IL-23 axis to the pathogenesis of inflammatory bowel disease. World J Gastroenterol. 21:5823–30.